YouTube Facebook LinkedIn Google+ Twitter Xingrss  

BMS Set to Win on Cancer Combinations


May 16, 2013 | Bristol-Myers Squibb's approved drug, Yervoy, is being tested in combination with several experimental drugs to treat advanced melanoma. The combination sets Bristol-Myers up for wins no matter which combination comes out on top. Forbes 
View Next Related Story
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.